HIV prevention in southern Africa: why we must reassess our strategies? - Test2 - elhamkhani - TriplyDB

HIV prevention in southern Africa: why we must reassess our strategies?

HIV prevention in southern Africa: why we must reassess our strategies?

http://www.wikidata.org/entity/Q37888766

about

Translation of biomedical prevention strategies for HIV: prospects and pitfalls.Improved outlook on HIV-1 prevention and vaccine development.Emtricitabine/tenofovir disoproxil fumarate: a review of its use in HIV-1 pre-exposure prophylaxis.From IEDs to AIDS? Detection of HIV in human corpses by rapid screening tests after suspected intentional transmission in terrorist attacks.

P2860

Q37051717-890ABD01-5320-474A-A853-8C272C864352 Q38009870-E322B845-3C56-40DD-8617-323FBDED5E54 Q38084940-ACAB99E2-5D01-4DAA-8A21-96EB5DE9893E Q39012322-A48E41C6-77CA-4AED-84F4-65FEAB771D1C

P2860

HIV prevention in southern Africa: why we must reassess our strategies?

http://www.wikidata.org/entity/Q37888766

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 June 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

HIV prevention in southern Africa: why we must reassess our strategies?

@en

HIV prevention in southern Africa: why we must reassess our strategies?

@nl

type

label

HIV prevention in southern Africa: why we must reassess our strategies?

@en

HIV prevention in southern Africa: why we must reassess our strategies?

@nl

prefLabel

HIV prevention in southern Africa: why we must reassess our strategies?

@en

HIV prevention in southern Africa: why we must reassess our strategies?

@nl

P1433

Q37888766-D70D3925-D6C4-4226-9232-D81E7FA73246

P1476

Q37888766-BF4CBEC2-E052-4107-ACDD-5F6B14C9E384

P2093

Q37888766-7F8ABF9E-7F4A-4C22-9FC3-ACD5937FB048

P2860

Q37888766-0112469B-434C-482A-9D81-10D98CDD6B5E

Q37888766-01FF3E98-8C43-4B7B-BA04-3B806D774C2F

Q37888766-020EBE34-D1F8-4C00-8707-93F2EAB40BDF

Q37888766-03011AD9-D9B8-4968-8220-E0EE83D3B451

Q37888766-05BE48A7-0C8A-4978-9B06-691C8F682AE6

Q37888766-061B3308-F592-4B87-8670-91E5E0E9E1EB

Q37888766-06F156FB-F6D1-4F3B-B0CF-B26DCBF4CA85

Q37888766-0D02C6DC-6F22-44A7-97C4-6F615D14E062

Q37888766-0E677C3F-3F09-4497-80D6-287266309363

Q37888766-0EEE652D-B2FD-4459-A9B0-7ECCFAC43F8E

P304

Q37888766-8E93D407-0C02-45D1-8C12-FD4048EFE603

P31

Q37888766-2B5F153E-EEBE-46BB-901E-0B52560B75E1

P356

Q37888766-9915274B-AA13-4E3F-971A-8C3EB7D0B56B

P433

Q37888766-68A96686-59CB-4B09-8866-C1086FE011D2

P478

Q37888766-31CBE2DF-B98F-4C67-89CC-E84D281F6CA9

P50

Q37888766-5AD0C350-5BCE-449F-925D-B9FBA1739AEE

P577

Q37888766-0AF32239-3BA5-4D5E-8D72-BC4A8C9AC63B

P5875

Q37888766-D7DBED57-33C5-4DB0-BC3A-72BCD13BAA66

P698

Q37888766-6149801D-32F3-4261-9A25-C844CDE97187

P921

Q37888766-220CC911-C0EE-48E9-A140-A43C8E3F1A1E

Q37888766-F4F31772-B582-4607-9722-2B99C2497E5C

P356

J.1365-3156.2011.02807.X

P1433

Tropical Medicine and International Health

P1476

HIV prevention in southern Africa: why we must reassess our strategies?

@en

P2093

James G Hakim

http://www.w3.org/2001/XMLSchema#string

P2860

Risk compensation is not associated with male circumcision in Kisumu, Kenya: a multi-faceted assessment of men enrolled in a randomized controlled trial

SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria

Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

Integrating HIV prevention and treatment: from slogans to impact

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

P304

1120-1130

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-3156.2011.02807.X

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51214818

http://www.w3.org/2001/XMLSchema#string

P698

21668592

http://www.w3.org/2001/XMLSchema#string

P921

Southern Africa

prevention of HIV/AIDS